Spark Therapeutics, Inc, 3737 Market St, Philadelphia, PA 19104, US

Rockland Immunochemicals is a global biotechnology company manufacturing leading edge research tools and cGMP grade proteins for basic, applied and clinical research in functional genomics, gene therapy and drug discovery markets. Rockland operates outside of Philadelphia. European and Asian markets are supported through a highly specialized network of key distributors. Rockland s antibodies are suited for individuals performing high throughput screening, drug discovery, diagnostic kit production and life science research. Primary antibodies include apolipoproteins, apoptosis/cell cycle, cytokines, cell signaling, enzymes, extracellular matrix, transcription factors (NFkB) and ubiquitin. Secondary antibodies are conjugated to a broad range of enzymes, fluorphors and magnetic particles.

Jiah Shin Teh MD

Andrew H. Milby, MD

Sherrie Davis, Aud

Rahul Kapur, MD - Penn Musculoskeletal Center